About the journal
JAPhA Practice Innovations is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 850 USD. Declared review time at DOAJ: 43 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2949-9690
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 850 USD
- Articles in DOAJ
- 49
- Declared review time
- 43 weeks
- Declared peer-review model
- other
- Official website
- https://www.sciencedirect.com/journal/japha-practice-innovations
Index listings
- DOAJ · 2025-01-08
- Indexing
- DOAJ
- APC
- 850 USD
- Declared review time (DOAJ)
- 43 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
49
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
43weeks
Works in OpenAlex
98
Last recorded publication year
2026
h-index
3
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2025-01-08
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 94%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918900802606676
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Pharmacy and Medical Practices
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Pharmacy and Medical Practices
- Pharmacy and Medical Practices
Show all subjects (75)
- Interprofessional Education and Collaboration
- Vaccine Coverage and Hesitancy
- Diabetes Treatment and Management
- Nursing Roles and Practices
- Nursing Roles and Practices
- Medication Adherence and Compliance
- Interprofessional Education and Collaboration
- Diabetes Management and Education
- Opioid Use Disorder Treatment
- Heart Failure Treatment and Management
- Interprofessional Education and Collaboration
- Heart Failure Treatment and Management
- Antibiotic Use and Resistance
- Substance Abuse Treatment and Outcomes
- HIV/AIDS Research and Interventions
- Antibiotic Use and Resistance
- Substance Abuse Treatment and Outcomes
- Health Policy Implementation Science
- Antibiotic Use and Resistance
- Diabetes Management and Research
- Substance Abuse Treatment and Outcomes
- Electronic Health Records Systems
- Diabetes Treatment and Management
- HIV, Drug Use, Sexual Risk
- Pharmaceutical studies and practices
- Electronic Health Records Systems
- Patient Safety and Medication Errors
- Health Policy Implementation Science
- Health Sciences Research and Education
- Pharmaceutical studies and practices
- HIV, Drug Use, Sexual Risk
- Pharmaceutical studies and practices
- Atrial Fibrillation Management and Outcomes
- Diabetes Treatment and Management
- Health Sciences Research and Education
- Electronic Health Records Systems
- Health Policy Implementation Science
- Patient Safety and Medication Errors
- Dietetics, Nutrition, and Education
- Atrial Fibrillation Management and Outcomes
- HIV/AIDS Research and Interventions
- Innovations in Medical Education
- Diabetes Management and Research
- Opioid Use Disorder Treatment
- Diabetes Management and Education
- Telemedicine and Telehealth Implementation
- Primary Care and Health Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Primary Care and Health Outcomes
- Vaccine Coverage and Hesitancy
- Diabetes Management and Education
- Opioid Use Disorder Treatment
- Vaccine Coverage and Hesitancy
- Diabetes Management and Research
- Innovations in Medical Education
- HIV/AIDS Research and Interventions
- Health Systems, Economic Evaluations, Quality of Life
- Atrial Fibrillation Management and Outcomes
- Patient-Provider Communication in Healthcare
- Health Promotion and Cardiovascular Prevention
- Pharmacology and Obesity Treatment
- Hospital Admissions and Outcomes
- HIV, Drug Use, Sexual Risk
- Innovations in Medical Education
- Pharmaceutical Economics and Policy
- Smoking Behavior and Cessation
Keywords (DOAJ)
- pharmacy practice
- public health promotion
- medication optimization
- pharmacotherapy
- new technologies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ